Hidden Enzyme KMT9 Helps Prostate Tumors Evade Immune Attack
New research reveals that the epigenetic enzyme KMT9 orchestrates immune evasion in prostate cancer by recruiting suppressive myeloid cells and ...
New research reveals that the epigenetic enzyme KMT9 orchestrates immune evasion in prostate cancer by recruiting suppressive myeloid cells and ...
Norwegian researchers found that pre-surgical serum immune-protein profiles, particularly reduced IL18, can identify prostate cancer patients at risk of biochemical ...
A large NHANES analysis of 7,174 American men found that serum cotinine, an objective biomarker of recent tobacco exposure, was ...
A prospective Danish study found that two PSMA PET tracers showed similar diagnostic accuracy for localising prostate tumours, with both ...
A study of 10,556 Brazilian prostate cancer patients found 87.7 percent five-year cancer-specific survival, with older age, lower education and ...
The largest dosimetry study of terbium-161 PSMA-617 radioligand therapy shows high tumor-absorbed doses with tolerable organ exposure in prostate cancer ...
New research shows that combining initial PSA levels with ISUP grade can reliably predict which prostate cancer patients will show ...
A prospectively validated urine-based proteomics test significantly outperformed PSA, MRI-based benchmarks, and risk calculators in predicting clinically significant prostate cancer ...
A prospective study of 142 patients finds that elevated baseline CEA independently predicts shorter survival in men with metastatic castration-resistant ...
A new Nature study integrates multiple classes of genomic mutations to define the distinct mutational processes that shape prostate cancer ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine